GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $356,000 | -83.6% | 5,221 | -93.0% | 0.00% | -50.0% |
| Q4 2021 | $2,177,000 | +45.3% | 74,400 | +26.5% | 0.00% | +100.0% |
| Q3 2021 | $1,498,000 | -66.9% | 58,793 | -54.5% | 0.00% | -75.0% |
| Q2 2021 | $4,525,000 | +370.4% | 129,200 | +447.5% | 0.00% | +300.0% |
| Q1 2021 | $962,000 | -3.4% | 23,600 | +2.6% | 0.00% | 0.0% |
| Q4 2020 | $996,000 | +9.1% | 23,000 | +22.2% | 0.00% | 0.0% |
| Q3 2019 | $913,000 | -73.3% | 18,817 | -71.1% | 0.00% | -75.0% |
| Q2 2019 | $3,419,000 | -42.3% | 65,000 | -42.0% | 0.00% | -42.9% |
| Q1 2019 | $5,928,000 | +6.5% | 112,007 | -17.4% | 0.01% | -12.5% |
| Q4 2018 | $5,564,000 | +63.8% | 135,522 | +51.7% | 0.01% | +100.0% |
| Q3 2018 | $3,396,000 | -16.4% | 89,360 | -0.5% | 0.00% | -33.3% |
| Q2 2018 | $4,060,000 | +76.9% | 89,828 | +54.0% | 0.01% | +100.0% |
| Q4 2017 | $2,295,000 | +11375.0% | 58,330 | +4760.8% | 0.00% | – |
| Q2 2016 | $20,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |